Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06641635 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06641635 · ClinicalTrials.gov record · last posted 2025-03-18

Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer

StatusRecruiting
PhasePhase 3
Started2024-11-19
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The most common external beam radiotherapy fractionation scheme for cervical cancer is 45-50.4 Gy delivered in 25-28 fractions. However, prolonged treatment duration can lead to insufficient availability of medical resources. We hope to assess the safety and efficacy of moderated hypofractionated online adaptive radiotherapy in combination with brachytherapy in patients with cervical cancer in a multicenter study.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2024-10-12. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-03-13
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT06641635
Lead Sponsor Peking Union Medical College Hospital
Collaborators: Peking University Cancer Hospital & Institute, Shandong Cancer Hospital and Institute, Ruijin Hospital
Conditions Cervical Cancer, Adaptive Radiotherapy
Enrollment 440 participants
Start Date 2024-11-19
Primary Completion 2026-10-31 (estimated)
Study Completion 2029-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-18